However, a randomized managed period II study in PDs didn't satisfy its Major final result and the drug enhancement was discontinued (NCT03318523). Autonomic dysfunction (Dysautonomia), parkinsonism, and cerebellar https://ksnr.org.in/multiple-system-atrophy/